SUStanford University logo

Stanford University Unclaimed

Academic Institutions

otl.stanford.edu

Stanford University is a leading research institution that commercializes innovations through its Office of Technology Licensing and the High Impact Technology Fund.

Stanford University is a premier research institution that translates early-stage discoveries into real-world impact through technology licensing and strategic funding. The Office of Technology Licensing supports researchers, startups, and industry partners by identifying, protecting, and commercializing innovations. Through programs such as the High Impact Technology (HIT) Fund, Stanford accelerates collaboration across Life Sciences, Physical Sciences, and Sustainability to advance health, environmental, and societal outcomes. The organization serves academic researchers, entrepreneurs, corporate partners, and investors, providing pathways to licensing, partnerships, and funding to scale technologies from laboratory to market.

To translate Stanford research into real-world benefits by licensing technologies, forming partnerships, and supporting high-impact research through targeted funding programs.

What we offer

Christa Biologics

Improves heart function through mitochondrial transplantation therapy.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/christa-biologics

DesRhex

Revolutionizes corneal transplantation by enhancing surgical precision.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/desrhex-corneal-endothelial

Exhalos

Enables early detection of necrotizing enterocolitis through non-invasive breath testing.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/exhalos-breath-testing

Immunera

Enables accurate diagnosis of autoimmune diseases through advanced technology.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/immunera-precision

Universal Vaccine Platform

Accelerates vaccine development for multiple pathogens and boosts public health readiness.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/universal-vaccine-platform

NOpioid

NOpioid offers an innovative solution for pain management without opioids.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/nopioid-next-generation-pain

Oligonucleotide Therapeutics

Target Specific Genes for Advanced Disease Treatment.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/oligonucleotide-therapeutics

Pediatric Sleep Apnea Testing Device

Essential Device for Assessing Pediatric Sleep Apnea.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/pediatric-sleep-apnea

Tracheal Acoustic Monitoring

Enables real-time detection of respiratory airflow for better health monitoring.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/tracheal-acoustic-monitoring

Wearable for Knee Osteoarthritis

Helps manage knee osteoarthritis through innovative wearable technology.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/wearable-knee-osteoarthritis

Haptica Robotics

Enables efficient training of robots through remote operation.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23physicalsciences/haptica-robotics

Photonic Routers for Solid-State Imaging

Enhances solid-state imaging systems through advanced routing of photonic signals.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23physicalsciences/photonic-routers-solid

Nanoscale Lithography

Enables Precise Nanoscale Patterning For Advanced Applications.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23physicalsciences/nanoscale-lithography

Immersive Virtual Acoustic Spaces

Create Realistic Audio Environments For Enhanced User Experiences.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/Immersive-virtual-acoustic-spaces

Magnefy

Enhances operational efficiency through predictive maintenance for power assets.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23physicalsciences/magnefy-predictive

Market segments

Market size by segment

Growth potential (CAGR)

Surgical and interventional devices

60 Billion USD6% CAGR

Devices for surgical and catheter-based interventions to repair or replace tissue and remove vascular obstructions.

Remote patient monitoring

28.6 Billion USD11.2% CAGR

Capabilities that collect, visualize, and act on continuous biometric and patient-reported data to support at-home monitoring and clinician-led interventions.

Biopharmaceutical platforms and therapeutics

155 Billion USD12.5% CAGR

Therapeutic platforms and next‑generation biologics including oligonucleotide therapies, universal vaccine platforms, and cell‑based treatments.

Advanced photonics and nanoscale fabrication

300 Billion USD7.5% CAGR

Photonics and nanoscale patterning technologies for imaging, sensing, and micro/nanofabrication in electronics, photonics, and biomedical devices.

Industrial automation and control systems

275 Billion USD9.6% CAGR

Integration of robotics, conveyors, custom machinery, UL-certified control panels and SCADA for production automation, real-time monitoring, and process optimization.

More information about our offering

Christa Biologics

Mitochondrial transplantation therapy for heart failure.

  • Enhances Heart Function
    This innovative therapy improves heart function by restoring energy levels in damaged heart cells, providing a potential remedy for heart failure.

DesRhex

Corneal endothelial transplant surgical device.

  • Enables Efficient Surgical Procedures
    This device allows for safer and more efficient surgical procedures during endothelial corneal transplants, ultimately improving patient outcomes.
  • Enhances Surgical Accuracy
    Utilizing state-of-the-art calibration and design, this device significantly improves the accuracy of corneal placement, reducing the risks associated with transplantation.

Exhalos

Breath testing for necrotizing enterocolitis.

  • Facilitates Early Diagnosis
    The Exhalos breath test provides a safe and effective method for identifying necrotizing enterocolitis in infants, allowing for timely intervention and improved patient outcomes.

Immunera

Precision diagnostics platform for autoimmune disease.

  • Provides Accurate Diagnoses
    Utilizes cutting-edge technology to deliver accurate diagnostic results, helping in the timely and effective management of autoimmune diseases.

Universal Vaccine Platform

The Universal Vaccine Platform is designed to accelerate the development and deployment of vaccines across various pathogens, promoting broad immunity and rapid public health responses.

  • Enables Diverse Vaccine Approaches
    Supports various vaccine types, including mRNA, protein subunit, and viral vectors, facilitating tailored responses to emerging infectious threats.
  • Accelerates Time to Market
    Utilizes innovative technologies to decrease the time needed for vaccine development, enabling quicker public health interventions.
  • Adapts to Changing Health Needs
    Easily customizable to address new variants and outbreaks, ensuring ongoing efficacy and relevance.
  • Streamlines Safety and Efficacy Trials
    Facilitates simultaneous clinical evaluation and regulatory compliance, ensuring rapid validation of vaccine candidates.

Milli-Spinner

Thrombectomy device for clot removal.

  • Restores Blood Flow
    The Milli-Spinner effectively clears thrombi, aiding vascular treatments and reducing complications associated with clot formation.

NOpioid

Next generation pain therapeutic.

  • Reduces Pain Effectively
    NOpioid utilizes cutting-edge research to provide effective pain relief, minimizing the reliance on traditional opioids.

Oligonucleotide Therapeutics

Oligonucleotide therapeutics are innovative medical treatments utilizing short strands of nucleic acids to target specific genes, providing potential therapies for a range of diseases.

  • Target Specific Genes
    Utilizes oligonucleotides to precisely target and modify gene expression, offering advanced treatment options for various genetic disorders.
  • Create Tailored Treatments
    Enables personalized medicine by designing oligonucleotides that match specific genetic profiles, optimizing therapeutic efficacy and minimizing side effects.
  • Accelerate Development
    The nature of oligonucleotide therapies allows for quicker transitions from research to clinical settings, enhancing timely patient care.
  • Address Diverse Diseases
    Applicable in treating genetic disorders, cancers, and infectious diseases, highlighting the broad therapeutic potential of oligonucleotides.

Pediatric Sleep Apnea Testing Device

Pediatric Sleep Apnea Testing Device that provides essential diagnostics for assessing sleep apnea in children, ensuring timely intervention and care.

  • Detects Sleep Apnea In Children
    This device effectively monitors and evaluates sleep patterns in children, offering precise diagnoses and guiding treatment options.

Tracheal Acoustic Monitoring

Tracheal acoustic monitoring to detect respiratory airflow.

  • Detects Airflow Instantly
    This feature allows for immediate detection of respiratory airflow changes, enabling timely interventions that could enhance patient health and safety.
  • Measures Without Surgery
    This feature means patients can receive critical airflow data without the need for invasive procedures, ensuring comfort and safety.

Wearable for Knee Osteoarthritis

Wearable for knee osteoarthritis.

  • Assists In Managing Pain
    This device provides targeted support for individuals with knee osteoarthritis, helping to alleviate pain and improve mobility.
  • Enables Personalized Feedback
    The device continuously monitors knee performance and offers real-time feedback to enhance user experience and rehabilitation.
  • Simplifies User Interaction
    The interface is intuitive, allowing users to easily track their progress and manage their condition without technical complications.

Haptica Robotics

Teleoperation platform for robot training.

  • Enhances Training Efficiency
    By allowing users to remotely control robots, the platform significantly enhances training efficiency and effectiveness, allowing for diverse and practical training scenarios.
  • Facilitates Immediate Corrections
    The platform allows trainers to make immediate corrections during sessions, thereby improving learning outcomes and skill acquisition for robots.
  • Simplifies Operation
    The interface is designed to simplify operations, making it accessible for users with varying levels of expertise.

Photonic Routers for Solid-State Imaging

Photonic routers for solid-state imaging.

  • Enable Efficient Signal Routing
    These routers facilitate the efficient routing of photonic signals, improving the overall performance and capabilities of solid-state imaging systems, enabling faster data processing and enhanced imaging resolution.

Nanoscale Lithography

Nanoscale Lithography facilitates precise patterning at the nanoscale, enabling advanced applications in fields such as electronics, photonics, and biomedicine. This innovative technology supports the fabrication of intricate structures essential for next-generation devices.

  • Achieves High-Resolution Designs
    This capability allows for the creation of intricate nanoscale patterns essential for the development of cutting-edge devices in electronics, photonics, and biomedicine.

Immersive Virtual Acoustic Spaces

Immersive virtual acoustic spaces enable the creation and exploration of realistic audio environments, enhancing user experiences across various applications.

  • Facilitates Engaging Audio Environments
    This feature allows users to craft detailed and interactive audio settings, enhancing user immersion through realistic soundscapes.
  • Enables Dynamic Audio Adjustments
    Users can interact with the virtual environment, leading to immediate audio modifications that respond to their actions, creating a seamless and fluid experience.
  • Increases Accessibility Across Devices
    Users can access the immersive acoustic spaces on different devices, expanding usability and user engagement.

Magnefy

Magnefy: Predictive maintenance solutions for critical power assets.

  • Optimize Maintenance Scheduling
    Allows for timely interventions to prevent failures, ensuring operational continuity and reducing downtime.
  • Enhance Decision-Making
    Empowers users with actionable insights for smarter operational decisions, resulting in cost savings and performance improvements.
  • Streamline User Access
    Facilitates easier interaction with complex data, making it accessible for all users regardless of technical background.

Kerra

Keratin-Based Platform to Replace Fossil-Fuel Materials.

  • Reduces Fossil Fuel Dependency
    By leveraging keratin as a bio-based material, this platform minimizes reliance on fossil fuels, promoting a more sustainable and eco-friendly approach to material production.
  • Enhances Environmental Responsibility
    Contributes to environmental sustainability by providing an alternative to conventional, petroleum-based materials.

References

Methodology and sourcing behind the figures shown above.

Surgical and interventional devices

Estimate derived by reconciling submarket figures in the provided search results: interventional cardiology devices (~USD 31.1B in 2026, CAGR 6.4%), minimally invasive devices (~USD 46.6B in 2024, CAGR ~4.4%), and powered surgical instruments (~USD 2.52B in 2026, CAGR 4.7%). To avoid double-counting (overlap between minimally invasive and interventional cardiology), the midpoint aggregation yields an approximate global surgical & interventional devices market of ~USD 60B (circa 2025–2026). Growth potential (CAGR ~6.0%) reflects the higher-growth interventional cardiology segment and broader medical-devices market trend (overall medical devices CAGR ~6.9%), balanced against slower segments in powered instruments and minimally invasive devices.

Remote patient monitoring

Estimates use multiple market reports in the search results. Global specialist reports cluster around mid-to-high $20–30B in the mid-2020s (GMI, MarketiQuest/LinkedIn). GMI reports USD 26.2B (2025) and USD 28.6B (2026) with 11.2% CAGR; MarketsandMarkets reports the US RPM market at USD 16.09B (2025) with a 12.6% US CAGR, indicating regional variance. Fortune Business Insights provides a higher 2025 estimate (USD 59.92B) and a higher CAGR (19.16%), representing a broader/alternative sizing. I selected a consensus global market size near USD 28.6B and a growth potential of ~11.2% CAGR reflecting corroborating sources.

Biopharmaceutical platforms and therapeutics

Estimated current (platforms & next‑gen biologics) market size by applying a 25–30% share to published global biopharmaceutical market values (SNS Insider, Precedence/ BioSpace, MarketDataForecast). SNS reports USD 486.15B (2023) and Precedence reports USD 537.54B (2025); applying ~30% yields ~146–161B and midpoint ≈155B. Growth CAGR set higher than broad biopharma because oligonucleotides, cell therapies and vaccine platforms are higher‑growth subsegments; supported by higher subsegment/platform CAGRs (drug discovery/platforms CAGR ~13.7% and Precedence biopharma CAGR 14.36%). A conservative blended CAGR of 12.5% reflects faster growth than legacy biologics but below the highest single forecast.

Advanced photonics and nanoscale fabrication

Estimated by anchoring to published global photonics market figures (~USD 1.05–1.09 trillion in 2025) and the advanced-optics submarket (~USD 287B in 2023). Advanced photonics/nanoscale fabrication (imaging, sensing, PICs, micro/nanofabrication) is treated as a material subset of the larger photonics market (roughly 25–35%), supplemented by a small but fast-growing nanopatterning market (~USD 2.95B in 2025). Weighted the dominant photonics growth (≈6.3–6.7% from industry reports) with higher-growth niches (advanced optics ≈9.2% and nanopatterning ≈14.6%) to derive a combined CAGR ~7.5%.

Industrial automation and control systems

Multiple market reports in the provided results converge on a ~USD 272–275 billion market size in 2025 and project high single-digit to ~10% CAGRs into the early 2030s. MarketsandMarkets reports USD 274.99B (2025) with a 9.6% CAGR to 2030; Fortune Business Insights reports USD 272.51B (2025) and ~9.8% mid-term CAGR; Coherent Market Insights gives a lower 2026 base but a similar high-single-digit CAGR (9.2%) to 2033. AlixPartners and others forecast the overall automation market surpassing USD 400B by 2030, supporting continued ~9–10% growth. I therefore estimate a current market size ≈ USD 275B and growth potential ~9.6% CAGR.

Related Organizations